# REGENERON PHARMACEUTICALS, INC. (REGN) FY2024 Q3 P&L / Income Statement

- Company: REGENERON PHARMACEUTICALS, INC. (REGN)
- Period: 2024-07-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-10-31, accession number 0001804220-24-000040
- Page: https://plicit.ai/financials/regn/fy2024-q3-income-statement
- Chart image: https://plicit.ai/charts/regn-fy2024-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2024-07-01 through 2024-09-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 3,720,700,000 US dollars
- **Cost of revenue (calculated)**: 491,100,000 US dollars
- **Gross profit (calculated)**: 3,229,600,000 US dollars
- **Operating expenses (calculated)**: 2,050,100,000 US dollars
- **Income from operations**: 1,179,500,000 US dollars
- **Total other income (expense)**: 313,500,000 US dollars
- **Income before income taxes**: 1,493,000,000 US dollars
- **Income tax expense**: 152,400,000 US dollars
- **Net income**: 1,340,600,000 US dollars
- **Inmazeb**: 35,600,000 US dollars
- **ELYEA HD And EYLEA - UNITED STATES**: 1,536,900,000 US dollars
- **ELYEA HD - UNITED STATES**: 392,300,000 US dollars
- **Evkeeza - UNITED STATES**: 32,400,000 US dollars
- **EYLEA Net Product Sales - UNITED STATES**: 1,144,600,000 US dollars
- **Libtayo - UNITED STATES**: 194,500,000 US dollars
- **Libtayo - Rest Of World**: 94,100,000 US dollars
- **Praluent - UNITED STATES**: 52,900,000 US dollars
- **Undisclosed (calculated)**: 237,400,000 US dollars
- **Cost of goods sold, collaboration and contract manufacturing**: 491,100,000 US dollars
- **Other operating expense (income), net**: 8,000,000 US dollars
- **Research and development**: 1,271,500,000 US dollars
- **Acquired in-process research and development**: 56,200,000 US dollars
- **Selling, general, and administrative**: 714,400,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (3 categories)

- Page: https://plicit.ai/financials/regn/fy2024-q3-income-statement/revenue-by-product-and-service-3-categories
- Chart image: https://plicit.ai/charts/regn-fy2024-q3-revenue-by-product-and-service-3-categories-sankey.png

Income statement for 2024-07-01 through 2024-09-30. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 3,720,700,000 US dollars
- **Cost of revenue (calculated)**: 491,100,000 US dollars
- **Gross profit (calculated)**: 3,229,600,000 US dollars
- **Operating expenses (calculated)**: 2,050,100,000 US dollars
- **Income from operations**: 1,179,500,000 US dollars
- **Total other income (expense)**: 313,500,000 US dollars
- **Income before income taxes**: 1,493,000,000 US dollars
- **Income tax expense**: 152,400,000 US dollars
- **Net income**: 1,340,600,000 US dollars
- **Net product sales**: 1,946,400,000 US dollars
- **Collaboration revenue**: 1,660,100,000 US dollars
- **Other revenue**: 114,200,000 US dollars
- **Cost of goods sold, collaboration and contract manufacturing**: 491,100,000 US dollars
- **Other operating expense (income), net**: 8,000,000 US dollars
- **Research and development**: 1,271,500,000 US dollars
- **Acquired in-process research and development**: 56,200,000 US dollars
- **Selling, general, and administrative**: 714,400,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (2 categories)

- Page: https://plicit.ai/financials/regn/fy2024-q3-income-statement/revenue-by-product-and-service-2-categories
- Chart image: https://plicit.ai/charts/regn-fy2024-q3-revenue-by-product-and-service-2-categories-sankey.png

Income statement for 2024-07-01 through 2024-09-30. View: Product and service (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 3,720,700,000 US dollars
- **Cost of revenue (calculated)**: 491,100,000 US dollars
- **Gross profit (calculated)**: 3,229,600,000 US dollars
- **Operating expenses (calculated)**: 2,050,100,000 US dollars
- **Income from operations**: 1,179,500,000 US dollars
- **Total other income (expense)**: 313,500,000 US dollars
- **Income before income taxes**: 1,493,000,000 US dollars
- **Income tax expense**: 152,400,000 US dollars
- **Net income**: 1,340,600,000 US dollars
- **Libtayo**: 288,600,000 US dollars
- **Inmazeb**: 35,600,000 US dollars
- **Undisclosed (calculated)**: 3,396,500,000 US dollars
- **Cost of goods sold, collaboration and contract manufacturing**: 491,100,000 US dollars
- **Other operating expense (income), net**: 8,000,000 US dollars
- **Research and development**: 1,271,500,000 US dollars
- **Acquired in-process research and development**: 56,200,000 US dollars
- **Selling, general, and administrative**: 714,400,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.